Erratum to: A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas

By Peereboom David   Supko Jeffrey   Carson Kathryn   Batchelor Tracy   Phuphanich Surasak   Lesser Glenn   Mikkelsen Tom   Fisher Joy   Desideri Serena   He Xiaoying   Grossman Stuart  

Journal of Neuro-Oncology, Vol. 100, Iss. 2, 2010-11 ,pp. : 269-269

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of sunitinib malate in patients with recurrent high-grade glioma

By Neyns B.   Sadones J.   Chaskis C.   Dujardin M.   Everaert H.   Lv S.   Duerinck J.   Tynninen O.   Nupponen N.   Michotte A.   Greve J.  

Journal of Neuro-Oncology, Vol. 103, Iss. 3, 2011-07 ,pp. : 491-501

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas

By van den Bent M.J.   Schellens J.H.M.   Vecht C.J.   Sillevis Smit P.A.E.   Loosveld O.J.L.   Ma J.   Tijssen C.C.   Jansen R.L.H.   Kros J.M.   Verweij J.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1570-1574

Elsevier

Access to resources Recommend Favorite

A multicenter phase I trial of combination therapy with interferon-β and temozolomide for high-grade gliomas (INTEGRA study): the final report

By Wakabayashi Toshihiko  

Journal of Neuro-Oncology, Vol. 104, Iss. 2, 2011-09 ,pp. : 573-577

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of temozolomide in children with recurrent high-grade glioma

By Ruggiero A.   Cefalo G.   Garré M.L.   Massimino M.   Colosimo C.   Attinà G.   Lazzareschi I.   Maurizi P.   Ridola V.   Mazzarella G.   Caldarelli M.   Rocco C.   Madon E.   Abate M.E.   Clerico A.   Sandri A.   Riccardi R.  

Journal of Neuro-Oncology, Vol. 77, Iss. 1, 2006-03 ,pp. : 89-94

Springer Publishing Company

Access to resources Recommend Favorite